Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FZ67V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,824
Award facts
- Contract value 100% obligated
- $21,823.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,823.86 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026 and serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad range of pharmaceutical products and medical commodities to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As the prime contractor under the DLA Troop Support Medical IDC, the company has demonstrated its capability to meet federal procurement requirements across multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical supplies. This delivery order for Dupixent, a biologic immunosuppressant used in dermatological and respiratory conditions, exemplifies the company's role in supporting military medical readiness through reliable provision of critical pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FZ67V?
SPE2DR26FZ67V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FZ67V worth?
The government has obligated $21,824 on SPE2DR26FZ67V.
Is contract SPE2DR26FZ67V an order under another contract?
Yes. SPE2DR26FZ67V is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ67V competed?
The extent of competition for SPE2DR26FZ67V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award